Arrowsmith is creating a world free from the pain and fear of antimicrobial resistance.
Arrowsmith has raised $6.5M in total funding. The most recent round was Series A. The last funding was announced in June 2026.
Arrowsmith's investors include JIC Venture Growth Investments, ANRI, JAFCO, DBJ Capital.
Arrowsmith is headquartered in Ibaraki, Japan.
Arrowsmith is creating a world free from the pain and fear of antimicrobial resistance.
Arrowsmith is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Arrowsmith — Funding & Investors." VCBacked, June 22, 2026, https://www.vcbacked.co/company/arrowsmith. Accessed November 12, 2026.
VCBacked. (2026). Arrowsmith — Funding & Investors. Retrieved November 12, 2026, from https://www.vcbacked.co/company/arrowsmith
{{cite web |title=Arrowsmith — Funding & Investors |url=https://www.vcbacked.co/company/arrowsmith |website=VCBacked |access-date=November 12, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Arrowsmith? Request a listing update